Amylyx Pharmaceuticals, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Amylyx Pharmaceuticals, Inc. (AMLX) is 17.85

According to Amylyx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 17.85. This represents a change of 30.92% compared to the average of 13.64 of the last 4 quarters.

Amylyx Pharmaceuticals, Inc. (AMLX) Historical Current Ratio (quarterly & annually)

How has AMLX Current Ratio performed in the past?

The mean historical Current Ratio of Amylyx Pharmaceuticals, Inc. over the last ten years is 6.20. The current 17.85 Current Ratio has changed 28.69% with respect to the historical average. Over the past ten years (40 quarters), AMLX's Current Ratio was at its highest in in the March 2026 quarter at 17.85. The Current Ratio was at its lowest in in the December 2020 quarter at 0.

Amylyx Pharmaceuticals, Inc. (AMLX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Amylyx Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Amylyx Pharmaceuticals, Inc. (AMLX) Average Current Ratio

How has AMLX Current Ratio performed in the past?

The current Current Ratio of Amylyx Pharmaceuticals, Inc. (AMLX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Amylyx Pharmaceuticals, Inc. (AMLX) Current Ratio vs. Peers

How is AMLX’s Current Ratio compared to its peers?

Amylyx Pharmaceuticals, Inc.’s Current Ratio is greater than ORIC Pharmaceuticals, Inc. (16.33), less than Relay Therapeutics, Inc. (22.13), greater than Inhibrx Biosciences, Inc. (6.46), greater than Syndax Pharmaceuticals, Inc. (5.47), greater than Nektar Therapeutics (10.21), greater than Atai Beckley Inc. (10.02), greater than Sana Biotechnology, Inc. (1.29), greater than Precigen, Inc. (4.82), greater than CureVac N.V. (3.70), greater than Immatics N.V. (8.78),

Build a custom stock screener for Amylyx Pharmaceuticals, Inc. (AMLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amylyx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amylyx Pharmaceuticals, Inc. (AMLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amylyx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.